DL
VRTX icon

Delta Lloyd’s Vertex Pharmaceuticals VRTX Stock Holding History

Delta Lloyd’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$3.29M Hold
25,491
– – 0.09% 207
2017
Q1 		$2.79M Hold
25,491
– – 0.08% 224
2016
Q4 		$1.88M Buy
25,491
+6,914
+37% +$563K 0.06% 263
2016
Q3 		$1.62M Buy
18,577
+3,272
+21% +$309K 0.05% 281
2016
Q2 		$1.32M Hold
15,305
– – 0.04% 307
2016
Q1 		$1.22M Sell
15,305
-3,434
-18% -$311K 0.04% 324
2015
Q4 		$2.36M Hold
18,739
– – 0.08% 181
2015
Q3 		$1.95M Buy
18,739
+2,009
+12% +$258K 0.06% 223
2015
Q2 		$2.07M Buy
16,730
+6,254
+60% +$788K 0.06% 216
2015
Q1 		$1.24M Hold
10,476
– – 0.04% 254
2014
Q4 		$1.25M Hold
10,476
– – 0.04% 253
2014
Q3 		$1.18M Buy
10,476
+2,023
+24% +$193K 0.01% 239
2014
Q2 		$800K Hold
8,453
– – 0.03% 294
2014
Q1 		$598K Sell
8,453
-279
-3% -$22.1K 0.02% 321
2013
Q4 		$649K Buy
8,732
+2,522
+41% +$176K 0.02% 295
2013
Q3 		$471K Buy
6,210
+1,089
+21% +$86.7K 0.02% 344
2013
Q2 		$410K Buy
+5,121
New +$377K 0.02% 356

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Delta Lloyd's VRTX Position: Q2 2017 in Review

Delta Lloyd held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2017 at 25,491 shares worth $3.29M. The position accounts for 0.09% of the portfolio, ranked #207.

Delta Lloyd first reported a position in VRTX in Q2 2013 and has held it in 17 quarters since. 582 funds tracked by Wall St. Rank hold VRTX as of Q2 2017.

  • Delta Lloyd held 25,491 shares of Vertex Pharmaceuticals worth $3.29M as of Q2 2017.
  • Delta Lloyd left its Vertex Pharmaceuticals share count unchanged in Q2 2017.
  • Vertex Pharmaceuticals made up 0.09% of Delta Lloyd's portfolio in Q2 2017, its #207 holding.
  • Delta Lloyd first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 17 quarters since.
  • 582 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2017.

Based on Delta Lloyd's 13F filing for Q2 2017, filed 9 Aug 2017.